CytomX Therapeutics, Inc. (CTMX)
5.37
-0.11
(-2.01%)
USD |
NASDAQ |
Feb 27, 16:00
5.355
-0.02
(-0.28%)
After-Hours: 20:00
CytomX Therapeutics Research and Development Expense (TTM) : 61.25M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| REGENXBIO, Inc. | 203.30M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |
| Alnylam Pharmaceuticals, Inc. | 1.320B |
| Savara, Inc. | 83.80M |
| BioMarin Pharmaceutical, Inc. | 700.97M |